Arphra/Issuer/CRDL

CRDL

Cardiol Therapeutics Inc.

HealthcareDrug Manufacturers - Specialty & GenericCAUSDCountry macro →

$1.22

LiveJun 01, 2026

AI Brief

Market cap

$136.48M

52w range

0.88 – 1.71

P / E

—

EPS

—

Volume

414.15K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Cardiol Therapeutics Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for CRDL.

Peers

No peer list available for CRDL.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
0.00%	-5.43%	-10.95%	+19.61%	+28.42%	+27.91%	-1.61%	+83.02%	-54.81%	-67.39%	-67.39%

Aftermarket

Live

Jun 01, 11:46 PM

Last trade

$1.22

273 sh

Bid

$1.19

300 sh

Ask

$1.27

200 sh

Spread

$0.080

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $8.00 (+555.74%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
prnewswire.com·May 07, 2026

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin